FOXO3 and hepatocellular carcinoma: Since high levels of FOXO3 in HCC patients seemed to be linked to a worse prognosis, we assessed FOXO3 expression and subcellular location in vitro to evaluate the possible FOXO3 upregulation in our sorafenib-resistant lines, which both resemble a more advanced disease stage.